Research and Development
CreaGen’s discovery research services currently supports several disease areas including metabolic syndrome, specifically Type II diabetes, infection, inflammation, CNS, neurodegeneration and oncology. Current programs encompass these important target classes that represent 70% of the drugs currently on the market.

CreaGen Team is constantly involved in developing novel preclinical candidates for our partners in the following areas:

• Synthetic small molecules and
• Natural Products

For more information
Please contact our R & D Coordinator
 
Company Profile
CreaGen Biosciences, Inc. is located in Woburn, MA, on the near north side of the Greater Boston Area. Boston is one of the primary hubs in the world for life sciences research.
(Corporate Fact Sheet)
 more...
News
  2009
Recent Developments
1) Press Release (PDF)
2)
Patent publication

Dr. Rajur chaired the medicinal chemistry symposium of the Northeastern section of American Chemical Society, Marriott Hotel, Burlington, MA, on September 10th, 2009. Symposium title "Recent Developments in Neurodegenerative diseases”

The Boston Society and NESACS applied pharmaceutical sciences and medicinal chemistry symposium titled"Frontiers in Strategies and Technologies to enrich pharmaceutical pipelines” held on
May 21-22, 2009 at the Merck Research Laboratories Boston Amphitheater, Boston, MA. was Hosted and co-sponsored in part by CreaGen Biosciences, Inc.

3rd Annual Advances In Chemical Sciences Symposium held on April 10, 2009 at the Royal Sonesta Hotel in Cambridge, MA. was Hosted and co-sponsored in part by CreaGen Biosciences, Inc.

  more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright 2009 CreaGen Biosciences Inc. All rights reserved.